Match!
Stuart G. Snowden
University of Cambridge
PathologyPsychologyDiseaseDiabetes mellitusBiomarker (medicine)
16Publications
5H-index
112Citations
What is this?
Publications 17
Newest
#1Stuart G. Snowden ('KCL': King's College London)H-Index: 5
#2Amera A. Ebshiana ('KCL': King's College London)H-Index: 2
Last. Madhav Thambisetty (NIH: National Institutes of Health)H-Index: 31
view all 9 authors...
Source
#1Samuel Furse (University of Cambridge)H-Index: 8
#2Stuart G. Snowden (University of Cambridge)H-Index: 5
Last. Albert Koulman (University of Cambridge)H-Index: 30
view all 9 authors...
We tested the hypothesis that both postnatal feeding and conditions in utero affect lipid metabolism in infants. Infants who experienced restrictive growth conditions in utero and others exposed to maternal hyperglycaemia were compared to a control group with respect to feeding mode. Dried blood spots were collected from a pilot subset of infant participants of the Cambridge Baby Growth Study at 3mo. Groups: (a) a normal gestation (control, n = 40), (b) small for gestational age (SGA, n = 34) an...
2 CitationsSource
#1Samuel Furse (University of Cambridge)H-Index: 8
#2Georgia BillingH-Index: 1
Last. Albert Koulman (University of Cambridge)H-Index: 30
view all 6 authors...
Introduction This study was motivated by the report that infant development correlates with particular lipids in infant plasma.
2 CitationsSource
#1Min Kim ('KCL': King's College London)H-Index: 6
#2Stuart G. Snowden (University of Cambridge)H-Index: 5
Last. Cristina Legido-Quigley ('KCL': King's College London)H-Index: 24
view all 51 authors...
Abstract Introduction A critical and as-yet unmet need in Alzheimer's disease (AD) is the discovery of peripheral small molecule biomarkers. Given that brain pathology precedes clinical symptom onset, we set out to test whether metabolites in blood associated with pathology as indexed by cerebrospinal fluid (CSF) AD biomarkers. Methods This study analyzed 593 plasma samples selected from the European Medical Information Framework for Alzheimer's Disease Multimodal Biomarker Discovery study, of i...
1 CitationsSource
#1Sarah WestwoodH-Index: 6
#2Alison L. BairdH-Index: 7
Last. Simon LovestoneH-Index: 83
view all 30 authors...
1 CitationsSource
#1Min KimH-Index: 6
#2Stuart G. SnowdenH-Index: 5
Last. Cristina Legido-QuigleyH-Index: 24
view all 27 authors...
Source
#1Stuart G. Snowden ('KCL': King's College London)H-Index: 5
#2Amera A. Ebshiana ('KCL': King's College London)H-Index: 2
Last. Madhav Thambisetty (NIH: National Institutes of Health)H-Index: 31
view all 9 authors...
INTRODUCTION: Three of the four treatments for Alzheimer9s disease are cholinesterase inhibitors targeting the pathological reduction of acetylcholine levels. Here we aimed to determine the role of other neurotransmitter pathways in AD pathology. METHODS: Tissue samples were obtained from three groups, controls, AD and 9asymptomatic AD9 i.e. cognitively normal individuals that had significant AD neuropathology. Three brain areas were studied, the middle frontal gyrus (MFG) the inferior temporal ...
Source
#1Min Kim ('KCL': King's College London)H-Index: 6
#2Alejo J. Nevado-Holgado (University of Oxford)H-Index: 8
Last. Cristina Legido-QuigleyH-Index: 24
view all 18 authors...
Lipids such as ceramides (Cer) and phosphatidylcholines (PC) have been found altered in the plasma of Alzheimer's disease (AD) patients in a number of discovery studies. For this reason, the levels of 6 ceramides and 3 PCs, with different fatty acid length and saturation levels, were measured in the plasma from 412 participants (AD n = 205, Control n = 207) using mass spectrometry coupled with ultra-performance liquid chromatography. After this, associations with AD status, brain atrophy, and ag...
15 CitationsSource
Source
#1Sarah WestwoodH-Index: 6
#2Abdul HyeH-Index: 17
Last. Simon LovestoneH-Index: 83
view all 47 authors...
Source
12